Discovery & Development

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What are biosynthetic cannabinoids? And what do they mean for pharma?

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

How easy will it be to bring a new solid oral dosage form to market?

How controlled release can lead to better compliance.

Can hot-melt coating reduced processing times and costs, and improve taste?

Developing a drug that hits a given target is one thing. Making sure it reaches the target is another.

Existing drugs can – and should – be repurposed to fight neglected diseases.

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

We must overcome the challenges of microparticulates to improve the patient experience.